Aclaris Therapeutics (ACRS) Return on Equity [ROE] (2015 - 2026)
Aclaris Therapeutics' Return on Equity [ROE] came in at -59.34% for Q2 2026, up 40.99 percentage points from -100.33% a year earlier and up 0.24 percentage points from the prior quarter.
Powered by 
Analysis
Aclaris Therapeutics (ACRS) Return on Equity [ROE] (2015 - 2026) Analysis & Trends
For FY2025, Aclaris Therapeutics' Return on Equity [ROE] was -53.15%, up 31.30 percentage points from FY2024.
- Return on Equity [ROE] carries a five-year change of +41.70 percentage points (FY2020 to FY2025).
- Going back by year, Return on Equity [ROE] was -84.46% in FY2024 (-34.58 pp), -49.88% in FY2023 (-5.87 pp), -44.01% in FY2022 (+33.33 pp) and -77.33% in FY2021 (+17.52 pp).
- The Q2 2026 figure represents the highest quarterly Return on Equity [ROE] since Q3 2024.
- Year-over-year, Return on Equity [ROE] has increased for three consecutive quarters, with an average year-over-year change of -8.62 percentage points over the last eight quarters.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in Q3 2021 (a gain of 89.17 percentage points), and the weakest in Q3 2025 (a drop of 86.33 percentage points).
- Business Quant data shows ACRS's Return on Equity [ROE] at -59.58% (Q1 2026), -61.60% (Q4 2025) and -115.32% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Aclaris Therapeutics | 625.92 Mn | 223.91 Mn | 1.29 Mn | -55.84% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -55.84% |
| Jun 30, 2026 | -57.06% |
| Mar 31, 2026 | -56.80% |
| Dec 31, 2025 | -57.72% |
| Sep 30, 2025 | -112.38% |
| Jun 30, 2025 | -96.96% |
| Mar 31, 2025 | -86.38% |
| Dec 31, 2024 | -92.31% |
| Sep 30, 2024 | -26.86% |
| Jun 30, 2024 | -42.08% |
| Mar 31, 2024 | -51.65% |
| Dec 31, 2023 | -55.94% |
| Sep 30, 2023 | -68.01% |
| Jun 30, 2023 | -58.95% |
| Mar 31, 2023 | -51.10% |
| Dec 31, 2022 | -41.96% |
| Sep 30, 2022 | -36.67% |
| Jun 30, 2022 | -40.59% |
| Mar 31, 2022 | -43.30% |
| Dec 31, 2021 | -43.97% |
API Access
Aclaris Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ACRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "ACRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ACRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();